Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane Multi-pass membrane protein Early endosome Note=Recruited to the cell membrane in response to low extracellular magnesium. |
Domain |
PF05653 Magnesium transporter NIPA |
Function |
Acts as a Mg(2+) transporter. Can also transport other divalent cations such as Fe(2+), Sr(2+), Ba(2+), Mn(2+) and Co(2+) but to a much less extent than Mg(2+) (By similarity). |
Biological Process |
GO:0015693 magnesium ion transport GO:0070838 divalent metal ion transport GO:0072511 divalent inorganic cation transport GO:1903830 magnesium ion transmembrane transport |
Molecular Function |
GO:0015095 magnesium ion transmembrane transporter activity GO:0046873 metal ion transmembrane transporter activity GO:0072509 divalent inorganic cation transmembrane transporter activity |
Cellular Component |
GO:0005769 early endosome |
KEGG | - |
Reactome |
R-HSA-5223345: Miscellaneous transport and binding events R-HSA-382551: Transmembrane transport of small molecules |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between NIPA1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of NIPA1 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of NIPA1 in various data sets.
|
Points in the above scatter plot represent the mutation difference of NIPA1 in various data sets.
|
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of NIPA1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of NIPA1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by NIPA1. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of NIPA1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of NIPA1 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between NIPA1 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | NIPA1 |
Name | non imprinted in Prader-Willi/Angelman syndrome 1 |
Aliases | MGC35570; SPG6; spastic paraplegia 6 (autosomal dominant); FSP3; non-imprinted in Prader-Willi/Angelman synd ...... |
Chromosomal Location | 15q11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting NIPA1 collected from DrugBank database. |
There is no record. |